Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-008608)

Filing Details

Accession Number:: 0001415889-25-008608
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-19 17:40:09
Reporting Period:: 2025-03-18

Filing Date:: 2025-03-19
Accepted Time:: 2025-03-19 17:40:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	Pharmaceutical Preparations (2834)	831281555

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1974200	Jolanda Howe	C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404	Svp, Global Controller	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-03-18	2,415	$44.45	2,426	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
The weighted average sale price for the transaction reported was $44.448421, and the range of prices were between $44.21 and $44.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.